Ordered stratification to reduce heterogeneity in linkage to diabetes-related quantitative traits.

Obesity
James B MeigsL Adrienne Cupples

Abstract

Phenotypic heterogeneity complicates detection of genomic loci predisposing to type 2 diabetes, potentially obscuring or unmasking specific loci. We conducted ordered-subsets linkage analyses (OSAs) for diabetes-related quantitative traits (fasting insulin and glucose, hemoglobin A1c (HbA1c), and 28-year-time-averaged fasting plasma glucose (FPG)) from 330 families of the Framingham Offspring Study. We calculated mean BMI, waist circumference (WC), and a diabetes "age-of-onset score" for each family. We constructed subsets by adding one family at a time in increasing (lean family to obese) or decreasing (obese to lean) adiposity order, or increasing or decreasing propensity to develop diabetes at a younger age, with the OSA LOD reported as the maximum LOD observed in any subset. Permutation P values tested the hypothesis that phenotypic ordering showed stronger linkage than random ordering. On chromosome 1, ordering by increasing family mean WC increased linkage to time-averaged FPG at 256 cM from LOD = 2.4 to 3.5 (permuted P = 0.02) and to HbA1c at 180 cM from LOD = 2.0 to 3.3 (P = 0.01). On chromosome 19, ordering by decreasing WC increased linkage to fasting insulin at 68 cM from LOD = 2.7 to 4.6 (P = 0.002), and ordering by...Continue Reading

References

Feb 1, 1981·American Journal of Epidemiology·W C KnowlerP H Bennett
Nov 1, 1994·Diabetes·G S Hotamisligil, B M Spiegelman
Feb 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·B D MitchellJ W MacCluer
Jan 1, 1995·Genetic Epidemiology·I B Borecki, G P Vogler
Sep 13, 1996·Science·N Risch, K Merikangas
Sep 26, 1997·The Journal of Clinical Investigation·E FerranniniG Mingrone
May 23, 1998·American Journal of Human Genetics·L Almasy, J Blangero
Mar 11, 2000·American Journal of Human Genetics·S C PrattL Kruglyak
Feb 26, 2003·Metabolism: Clinical and Experimental·Ping AnD C Rao
May 6, 2003·Current Diabetes Reports·Mark I McCarthy
Aug 23, 2003·Biostatistics·H K Tang, D Siegmund
Oct 7, 2003·Annual Review of Genomics and Human Genetics·Jose C FlorezDavid Altshuler
Dec 25, 2003·Obesity Research·Roberto ElosuaJose M Ordovas
Jun 9, 2004·Genetic Epidemiology·Elizabeth R HauserMichael Boehnke
Jun 1, 2006·The Journal of Clinical Endocrinology and Metabolism·James B MeigsRalph B D'Agostino
Jan 11, 2007·The Journal of Clinical Endocrinology and Metabolism·Jose C FlorezUNKNOWN Diabetes Prevention Program Research Group
Oct 16, 2007·BMC Medical Genetics·James B MeigsJosée Dupuis
Oct 17, 2007·Annual Review of Medicine·Allan F Moore, Jose C Florez

❮ Previous
Next ❯

Citations

Mar 12, 2009·Genetic Epidemiology·Josée DupuisDavid Siegmund
Jul 9, 2009·Physiological Genomics·Marcelo A NobregaHoward J Jacob

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
Woranan CharoenhirunyingyosSathit Vannasaeng
Archives of Ophthalmology
Pascale MassinDESIR (Data From an Epidemiological Study on the Insulin Resistance Syndrome) Study Group
© 2022 Meta ULC. All rights reserved